IMPLEMENTATION OF GLOBAL LICENSE TO AUREUS PHARMA'S KNOWLEDGE DATABASES BY GLAXOSMITHKLINE
Aureus Pharma a leading provider of knowledge management solutions to aid discovery
in the life sciences industry, today announces that GlaxoSmithKline (GSK) has
signed a multi-year license for Aureus Pharma's AurSCOPE Knowledge databases.
Researchers at GSK's global research and development centers will gain access
to Aureus' Knowledge databases including AurSCOPE GPCR, Ion Channel, hERG, and
ADME/Drug-Drug Interactions. In addition, GSK has licensed the recently released
AurSCOPE Kinase product making it the first customer of this knowledge base
which is of major importance for oncology and other diseases. Financial details
were not disclosed.